CRVS position history
The shares of Corvus Pharmaceuticals (CRVS) that Avidity Partners Management LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 230,000 shares, $3.4M, 0.40% of portfolio, New
- 2026 Q2: 80,000 shares, $1.2M, 0.19% of portfolio, Reduce −65.2%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|